Sleep Apnea and Glaucoma: What the Science Shows

Every night, roughly 30 million Americans stop breathing repeatedly while they sleep. Most of them do not know it.

Obstructive sleep apnea is one of the most common chronic health conditions in the country, and estimates suggest up to 80 percent of moderate-to-severe cases go undiagnosed. Most of the conversation around sleep apnea focuses on the heart, blood pressure, and daytime fatigue. But over the past several years, researchers have been building a case for a different connection: between the repeated oxygen drops that happen during apnea events and the long-term health of the optic nerve.

This post looks at what the science shows, where the evidence is clear, where it gets more complicated, and what it means if you have been diagnosed with glaucoma or are at risk for it.

What Happens in Your Body During an Apnea Event

Sleep apnea is not just loud snoring. During an obstructive apnea event, the airway collapses, airflow stops, and blood oxygen levels drop. The brain eventually registers the problem and triggers a partial awakening, just enough to restart breathing. This cycle can happen dozens or even hundreds of times a night.

Each event puts the body through a sequence: oxygen deprivation, followed by a surge of sympathetic nervous system activity as breathing resumes. Over years, this pattern stresses the cardiovascular system, elevates blood pressure, and promotes systemic inflammation.

The eyes are not isolated from any of this. The optic nerve has an extremely high metabolic demand. The retinal ganglion cells whose axons make up the optic nerve are among the most energy-hungry neurons in the body. They depend on consistent, reliable oxygen delivery. When that delivery is disrupted night after night, year after year, the potential for cumulative damage is real.

The Research: Oxygen and the Optic Nerve

One of the most important recent studies on this topic comes from Japan. In 2024, Nagasaki et al. published findings from the Nagahama Study in the Annals of the American Thoracic Society. Their dataset included 8,309 community residents who wore actigraphy devices to track sleep patterns.

The researchers focused on what they called cumulative hypoxemic burden: the total time each night a person's blood oxygen saturation dropped below 90 percent. After adjusting for age, sex, and other relevant factors, this measure was significantly associated with retinal nerve fiber layer (RNFL) thinning. RNFL thinning is the primary structural marker for glaucomatous optic nerve damage.

The finding held in both older and younger participants. The greater the cumulative oxygen debt each night, the thinner the nerve fiber layer.

A 2025 study published in Biomedicines from a Taiwan hospital added another dimension. Researchers examined 57 confirmed OSA patients who used CPAP therapy versus those who did not. Higher air leakage from the CPAP mask was significantly associated with both a higher cup-to-disc ratio (a structural sign of optic nerve stress) and lower tear production (a dry eye marker). Poorly fitting CPAP therapy may fail to adequately protect the optic nerve even when it is technically in use.

Here Is Where It Gets More Complicated

The evidence does not all point in one direction, and honesty about that matters.

A large French multicenter prospective cohort study published in Sleep Medicine included 9,580 patients over age 50, of whom 6,754 had confirmed OSA. After controlling for age, BMI, sex, blood pressure, triglycerides, and thyroid function, the OSA diagnosis itself did not significantly predict higher odds of glaucoma.

This is not a contradiction so much as a clarification. OSA is not uniformly dangerous for the optic nerve across all patients. The degree and duration of oxygen deprivation may matter more than the diagnosis on paper. A patient with mild OSA and minimal oxygen drops is in a different situation from someone with severe OSA and sustained periods of low blood oxygen each night.

There is also an important nuance about intraocular pressure (IOP). Early researchers expected apnea events to cause IOP spikes that would damage the optic nerve the way elevated pressure does in typical open-angle glaucoma. Studies found the opposite: during apnea events, IOP tends to drop rather than spike. The mechanism connecting OSA to optic nerve damage appears to be oxygen deprivation and vascular stress, not pressure elevation.

The Normal-Tension Glaucoma Connection

This distinction is especially significant for people with normal-tension glaucoma (NTG): a form of glaucoma where optic nerve damage progresses even when IOP is in the normal range. Researchers have long known that NTG has a strong vascular component. Something other than elevated pressure is damaging the nerve.

OSA is now considered a clinically relevant factor in NTG specifically. The repeated cycles of hypoxia and vascular stress during apnea events compromise circulation at the optic nerve head in ways that are independent of IOP. For patients with progressive NTG whose eye pressure appears well controlled, sleep apnea is a reasonable question to raise with their physician.

As our post on nicotinamide and glaucoma explains, the field of glaucoma neuroprotection has grown significantly in recent years precisely because IOP management alone does not fully explain or stop disease progression in many patients. Sleep apnea is part of that larger conversation about what else contributes to optic nerve stress.

What to Do With This Information

A few practical points.

If you have glaucoma and have never been evaluated for sleep apnea: bring it up with your doctor. It is a simple ask, and it could affect how your care team thinks about your progression. Conversely, if you are being treated for sleep apnea, make sure your eye doctor knows. It is clinically relevant history.

CPAP mask fit matters. The 2025 Biomedicines study found that air leakage from CPAP masks was the variable most consistently associated with optic nerve stress markers. If you use CPAP therapy, work with your sleep specialist to ensure the mask is properly sealed. Suboptimal therapy may not be delivering the protection you think it is.

The good news: OSA is treatable. When CPAP therapy is worn correctly and consistently, blood oxygen levels during sleep are restored. The American Academy of Ophthalmology notes that properly treated OSA reduces risk for several serious eye conditions.

This is not a call for alarm. It is a call for awareness and coordination between two medical specialties that do not always talk to each other.

What Does This Mean for You?

Your optic nerve does not stop needing oxygen when you close your eyes. The retinal ganglion cells that form it are working all night. Research connecting sleep apnea to RNFL thinning is serious enough to take seriously, even if the full clinical picture is still emerging.

Talk to your doctors about both sides of this. Sleep medicine and ophthalmology are not typically coordinated, but there is a growing case that they should be when both conditions are present.

For people who want to take a proactive approach to optic nerve cellular health alongside their standard care, Sight Guard was formulated to support cellular energy in the eye. As we explain on our science page, supporting the mitochondrial energy pathways that retinal ganglion cells depend on is the central idea behind the product. It is not a substitute for any prescribed care or treatment, and it does not address sleep apnea directly. It is designed to complement your existing routine.

References

1. Nagasaki T et al., "Associations between Nocturnal Hypoxemia and Retinal Nerve Fiber Layer Thinning: The Nagahama Study." Annals of the American Thoracic Society, 2024, 21(4):644-650. PMID: 38241090. DOI: 10.1513/AnnalsATS.202304-355OC.

2. Wang WX et al., "Impact of Positive Airway Pressure and Mask Leakage on Dry Eye and Glaucoma Risk in Obstructive Sleep Apnea: A Cross-Sectional Analysis." Biomedicines, 2025, 13(12). PMID: 41463088. DOI: 10.3390/biomedicines13123077.

3. Aptel F et al., "Association between glaucoma and sleep apnea in a large French multicenter prospective cohort." Sleep Medicine, 2014, 15(5):576-581. PMID: 24780132. DOI: 10.1016/j.sleep.2013.11.790.

4. American Academy of Ophthalmology. "Sleep Apnea and Glaucoma." https://www.aao.org/eye-health/tips-prevention/obstructive-sleep-apnea-glaucoma

5. Glaucoma Research Foundation. "How Sleep Apnea May Contribute to Normal-Tension Glaucoma Risk." https://glaucoma.org/articles/how-sleep-apnea-may-contribute-to-normal-tension-glaucoma-risk